Advertisement

Journal of Sol-Gel Science and Technology

, Volume 50, Issue 3, pp 421–429 | Cite as

Influence of mesoporous structure type on the controlled delivery of drugs: release of ibuprofen from MCM-48, SBA-15 and functionalized SBA-15

  • Isabel Izquierdo-Barba
  • Edesia Sousa
  • Juan Carlos Doadrio
  • Antonio Luis Doadrio
  • Joaquín Pérez Pariente
  • Africa Martínez
  • Florence Babonneau
  • María Vallet-RegíEmail author
ORIGINAL PAPER

Abstract

Ordered mesoporous materials exhibit potential features to be used as controlled drug delivery systems, including their wide range of chemical compositions and their outstanding textural and structural properties. Therefore, it is possible to control the drug release kinetics by tailoring such parameters. In this paper, mesoporous materials such as MCM-48 and SBA-15, which present different pore sizes (3.7 and 8.8 nm) and structural characteristics (3D-bicontinuous cubic and 2D-hexagonal, respectively) have been synthesized to evaluate their application as drug delivery system and to determine their influence on release kinetic of ibuprofen. Moreover, a chemical modification of the SBA-15 mesoporous material with octadecyltrimethoxysilane has also been performed to study its influence on the release rate of ibuprofen. The structural characteristics (3D cubic and 2D hexagonal pore system) do not affect the release kinetic profiles of ibuprofen. On the contrary, the pore size affects highly to the release kinetic profiles from first-order kinetic to zero-order kinetic for MCM-48 and SBA-15, respectively. Moreover, the importance of surface functionalization was demonstrate through the very fast delivery of ibuprofen from SBA-15 mesoporous materials functionalized with octadecyl chains.

Keywords

Ordered mesoporous materials Structural characteristics 2D-hexagonal 3D-bicontinuous cubic structure and functionalization 

Notes

Acknowledgments

Financial support of CICYT Spain, through research projects MAT2005-01486 and CAM S-0505/MAT/000324 is acknowledged.

References

  1. 1.
    Ying JY, Mehner CP, Wong MS (1999) Angew Chem Int Ed 38:56. doi: 10.1002/(SICI)1521-3773(19990115)38:1/2<56::AID-ANIE56>3.0.CO;2-E CrossRefGoogle Scholar
  2. 2.
    Soler-Illia GJAA, Sanchez C, Lebeau B, Patarin J (2002) Chem Rev 102:4093. doi: 10.1021/cr0200062 PubMedCrossRefGoogle Scholar
  3. 3.
    Lapkin A, Bozkaya B, Mays T, Borello L, Edler K, Crittenden B (2003) Catal Today 81:611. doi: 10.1016/S0920-5861(03)00159-7 CrossRefGoogle Scholar
  4. 4.
    Lan EH, Dave BC, Fukutu JM, Dunn BS, Zink JI, Valentino JS (1999) J Mater Chem 9:45. doi: 10.1039/a805541f CrossRefGoogle Scholar
  5. 5.
    MacGrath KM, Dabbs DM, Yao N, Elder KJ, Akasay IA, Gruner SM (2000) Langmuir 16:398. doi: 10.1021/la990098z CrossRefGoogle Scholar
  6. 6.
    Vallet-Regí M, Ramila A, Del Real RP, Pérez-Pariente J (2001) Chem Mater 13:311. doi: 10.1021/cm0011559 CrossRefGoogle Scholar
  7. 7.
    Vallet-Regí M, Balas F, Colilla M, Manzano M (2007) Solid State Sci 9:768. doi: 10.1016/j.solidstatesciences.2007.03.026 CrossRefADSGoogle Scholar
  8. 8.
    Vallet-Regí M, Balas F, Colilla M, Manzano M (2007) Drug Metab Lett 1:37. doi: 10.2174/187231207779814382 PubMedCrossRefGoogle Scholar
  9. 9.
    Vallet-Regí M, Balas F, Arcos D (2007) Angew Chem Int Ed 47:7448Google Scholar
  10. 10.
    Vallet-Regí M (2006) Chem Eur J 12:5934. doi: 10.1002/chem.200600226 CrossRefGoogle Scholar
  11. 11.
    Salonen J, Laitinen L, Kaukonen AM, Tuura J, Björkqvist M, Heikkilä T, Vähä-Heikkilä K, Hirvonen J, Lehto V-P (2005) J Control Release 108:362. doi: 10.1016/j.jconrel.2005.08.017 PubMedCrossRefGoogle Scholar
  12. 12.
    Langer R (1999) J Control Release 62:7. doi: 10.1016/S0168-3659(99)00057-7 PubMedCrossRefGoogle Scholar
  13. 13.
    Mellaerts R, Mols R, Jammaer JAG, Aerts CA, Annaert P, Humbeeck JV, Van den Mooter G, Augustijns P, Martens JA (2008) Eur J Pharm Biopharm 1:223. doi: 10.1016/j.ejpb.2007.11.006 CrossRefGoogle Scholar
  14. 14.
    Shin Y, Chang JH, Liu J, Williford R, Shin YK, Exarhos GJJ (2001) Contr Release 73:1. doi: 10.1016/S0168-3659(01)00247-4
  15. 15.
    Doadrio JC, Arcos D, Cabañas MV, Vallet-Regí M (2004) Biomaterials 25:2629. doi: 10.1016/j.biomaterials.2003.09.037
  16. 16.
    Yanagisawa T, Shimizu T, Kuroda K, Kato C (1990) Bull Chem Soc Jpn 63:988. doi: 10.1246/bcsj.63.988 Google Scholar
  17. 17.
    Kresge CT, Leonowicz ME, Roth WJ, Vartuli JC, Beck JS (1992) Nature 359:710. doi: 10.1038/359710a0
  18. 18.
    Horcajada P, Rámila A, Pérez-Pariente J, Vallet-Regí M (2004) Microporous Mesoporous Mater 68:105. doi: 10.1016/j.micromeso.2003.12.012
  19. 19.
    Nieto A, Balas F, Colilla M, Manzano M and Vallet-Regí M (2008) Micropor Mesopor Mater doi:  10.1016/j.micromeso.2008.03.025
  20. 20.
    Izquierdo-Barba I, Martínez A, Doadrio AL, Pérez-Pariente J, Vallet-Regí M (2005) Eur J Pharm Sci 26:365. doi: 10.1016/j.ejps.2005.06.009 Google Scholar
  21. 21.
    Doadrio JC, Sousa EMB, Izquierdo-Barba I, Doadrio AL, Pérez-Pariente J, Vallet-Regí M (2006) J Mater Chem 16:462. doi: 10.1039/b510101h Google Scholar
  22. 22.
    Muñoz B, Ramila A, Perez-Pariente J, Diaz I, Vallet-Regí M (2003) Chem Mater 15:500. doi: 10.1021/cm021217q
  23. 23.
    Song S-W, Hidajat K, Kawi S (2005) Langmuir 21:9568. doi: 10.1021/la051167e
  24. 24.
    Balas F, Manzano M, Horcajada P, Vallet-Regí M (2006) J Am Chem Soc 128:8116. doi: 10.1021/ja062286z Google Scholar
  25. 25.
    Zhao DY, Feng JL, Huo QS, Melosh N, Fredrickson GH, Chmelka BF, Stucky GD (1998) Science 279:548. doi: 10.1126/science.279.5350.548
  26. 26.
    Che S, Lund K, Tatsumi T, Iijima S, Joo SH, Ryoo R, Terasaki O (2003) Angew Chem Int Ed 42:2182. doi: 10.1002/anie.200250726 Google Scholar
  27. 27.
    Kaneda M, Tsubakiyama T, Carlsson A, Sakamoto Y, Oshuna T, Terasaki O, Joo H, Ryoo R (2002) J Phys Chem B 106:1256. doi: 10.1021/jp0131875
  28. 28.
    Sakamoto Y, Kim TW, Ryoo R, Terasaki O (2004) Angew Chem Int Ed 43:5231. doi: 10.1002/anie.200460449 Google Scholar
  29. 29.
    Grün M, Kurganov AA, Schacht S, Schüth F, Unger KK (1996) J Chromatogr A 740:1. doi: 10.1016/0021-9673(96)00205-1 CrossRefGoogle Scholar
  30. 30.
    Zhao D, Huo Q, Fena J, Chmelka BF, Stucky GD (1998) J Am Chem Soc 120:6024. doi: 10.1021/ja974025i CrossRefGoogle Scholar
  31. 31.
    Kim JM, Kim SK, Ryoo R (1998) Chem Commun (Camb) 259. doi: 10.1039/a707677k
  32. 32.
    Kokubo T, Kushitani H, Sakka S, Kisugi T, Yamamuro T (1990) J Biomed Mater Res 24:721. doi: 10.1002/jbm.820240607 PubMedCrossRefGoogle Scholar
  33. 33.
    Kruk M, Jaroniec M, Sayari A (1997) J Phys Chem B 101:583. doi: 10.1021/jp962000k CrossRefGoogle Scholar
  34. 34.
    Kruk M, Jaroniec M, Sarayi A (1997) Langmuir 13:6267. doi: 10.1021/la970776m CrossRefGoogle Scholar
  35. 35.
    Bacile N, Laurent G, Bonhomme C, Innocenza P, Babonneau F (2007) Chem Mater 19:1343. doi: 10.1021/cm062545j CrossRefGoogle Scholar
  36. 36.
    Babonneau F, Camus L, Steunou N, Ramila A, Vallet-Regi M (2003) Mater Res Soc Symp Proc 775:77Google Scholar
  37. 37.
    Azaïs T, Tourné-Péteilh C, Aussenac F, Baccile N, Coelho C, Devoisselle J-M, Babonneau F (2006) Chem Mater 18:6382. doi: 10.1021/cm061551c CrossRefGoogle Scholar
  38. 38.
    Babonneau F, Yeung L, Steunou N, Gervais C, Muñoz B, Ramila A, Vallet-Regi M (2004) J Sol-Gel Sci Techn 31:219CrossRefGoogle Scholar
  39. 39.
    Costa P, Sousa-Lobo JM (2001) Eur J Pharm Sci 13:123. doi: 10.1016/S0928-0987(01)00095-1 PubMedCrossRefGoogle Scholar
  40. 40.
    Ramila A, Muñoz B, Perez-Pariente J, Vallet-Regí M (2003) J Sol-gel Sci Tech 26:1199CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Isabel Izquierdo-Barba
    • 1
    • 2
  • Edesia Sousa
    • 1
  • Juan Carlos Doadrio
    • 1
  • Antonio Luis Doadrio
    • 1
  • Joaquín Pérez Pariente
    • 1
  • Africa Martínez
    • 1
  • Florence Babonneau
    • 3
  • María Vallet-Regí
    • 1
    • 2
    Email author
  1. 1.Departamento de Química Inorgánica y Bioinorgánica, Facultad de FarmaciaUniversidad ComplutenseMadridSpain
  2. 2.Centro de Investigación Biomédica en Red, Bioingeniería, Biomateriales y Nanomedicina, CIBER-BBNMadridSpain
  3. 3.Chimie de la Matière Condensée de ParisUPMC-Paris6 and CNRSParisFrance

Personalised recommendations